🍎 🍕 Less apples, more pizza 🤔 Have you seen Buffett’s portfolio recently?Explore for Free

U.S. has administered over 422 million doses of COVID-19 vaccines -CDC

Published 10/31/2021, 05:38 PM
Updated 10/31/2021, 05:40 PM
© Reuters. FILE PHOTO: A nurse receives one of the first vaccinations at Mt. Sinai Hospital from Pfizer-BioNTech during the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., December 15, 2020. REUTERS/Carlo Allegri/Fi
PFE
-
JNJ
-
MRNA
-

(Reuters) - The United States had administered 422,070,099 doses of COVID-19 vaccines in the country as of Sunday morning, the U.S. Centers for Disease Control and Prevention said.

Those figures were up from the 420,657,683 vaccine doses the CDC said had gone into arms by Saturday.

The agency said 221,520,153 people had received at least one dose, while 192,453,500 people were fully vaccinated as of 6 a.m. EDT on Sunday.

© Reuters. FILE PHOTO: A nurse receives one of the first vaccinations at Mt. Sinai Hospital from Pfizer-BioNTech during the coronavirus disease (COVID-19) pandemic in the Manhattan borough of New York City, New York, U.S., December 15, 2020. REUTERS/Carlo Allegri/File Photo

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:MRNA) Inc and Pfizer (NYSE:PFE) Inc/BioNTech, as well as Johnson & Johnson (NYSE:JNJ)'s one-shot vaccine.

About 18.6 million people have received a booster dose of either Pfizer, Moderna or Johnson & Johnson's COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.